Russian Conference “Association of Epileptologists and Patients” took
place on February 27, 2015 in the hotel “Holiday Inn Moskovskye Vorota”
in St. Petersburg. The theme of the conference was: “Remission of
epilepsy. Modern possibilities and achievements in Russia.”
The conference was held with the support of the Committee for Public
Health of St. Petersburg, the St. Petersburg V.M. Bekhterev
Psychoneurological Research Institute, the Institute of the Human Brain
n.a. N.P.Behtereva and Palms of the World association. GEROPHARM, one of
the leading Russian pharmaceutical manufacturers, actively participated
in the conference. Neurology is a traditional area of specialization of
the company. In 2013 GEROPHARM manufactured some modern, high quality
and affordable generics, including Levetinol® which is used in epilepsy treatment.
Epilepsy is one of the most widespread onset of nervous system
disorders. The incidence of epilepsy is 30-50 per 100,000 people
(0.05%). Number of patients with epilepsy in the world is about 30
million people. In Europe there are 3 million patients, in the United
States - 4 million, in Russia - 500 thousand. Every year in Russia 54
thousand patients fall ill with epilepsy.
The conference featured presentations of leading experts. They were
focused on current problems of this socially significant disease
treatment and its prevention among adults and children.
In their reports Maxim A. Yamin (main epileptologist of the Russian
Ministry of Health, head of the regional epilepsy centre in
Rostov-on-Don) and Kira V. Voronkova, (Professor and Doctor of Medical
Science of the Pirogov Russian National Research Medical University and
vice president of Moscow Association of Epileptologists and Patients)
described and justified the experience of using Levetinol as the
first-line therapy of focal epilepsy in Russia. They also presented the
analysis of a clinical case in which Levetinol demonstrated its high
efficacy and safety.
An exhibition was also held during the conference. Leading Russian and
foreign manufacturers of pharmaceutical products and medical devices
took part in it. GEROPHARM had its own booth where the company showed a
portfolio of drug products and production capabilities.
Epilepsy Day officially celebrated on the second Monday in February.
At the age of nine Cassidy Megan from Scotland, already experienced the
neglect of others, came up to celebrate “Purple Day”. With the help of
this event more people could know about this disease, no longer wary of
her and would be able to support patients with epilepsy. On March 26,
2008, with the assistance of the Epilepsy Association of Nova Scotia, it
was decided to celebrate Purple Day and European Epilepsy Day. The
following year more than 100 non-governmental organizations participated
in its celebration. In February medical and public organisations
celebrate Purple Day carrying out various activities. Their goal is to
increase public awareness of epilepsy and teach how to perform first aid
for an epilepsy seizure.
Purple or lavender is the international colour of epilepsy, because
it has a positive effect on the nervous system and reduces anxiety.
Epilepsy Day in Russia
For the fist time Epilepsy Day was celebrated in Russia on March 10, 2011. International Epilepsy Day will be celebrated for the first time in 2015.